Onglyza heart failure lawsuits filed by Jones Ward PLC

A growing number of diabetes patients are seeking legal help after being diagnosed with heart failure while taking the drugs Ongylza and Kombiglyze XR. The dangerous drug lawyers at Jones Ward PLC have filed two of the only lawsuits in federal court in pursuit of justice for these injuries. Ongylza and Kombiglyze XR are used by thousands of… Read More

Onglyza Linked to Increased Heart Failure

Onglyza Linked to Increased Heart Failure

Jones Ward is investigating claims related to the diabetes drug Onglyza to cause heart failure or death. Onglyza is prescribed to treat symptoms of Type 2 Diabetes and is intended to lower glucose levels and other complications associated with Adult Type 2 diabetes. Why is Onglyza Under Review? According to the Food and Drug Administration,… Read More

Express Scripts Drops Onglyza From Its 2016 Formulary

Express Scripts Drops Onglyza From Its 2016 Formulary

One of the largest pharmacies in the United States has dropped the diabetes drug Onglyza from its formulary, which is a list of drugs covered by insurance. Out of around 4,000 medications on the U.S. market, Express Scripts did not include 80 drugs on its 2016 formulary. If you’ve been harmed by this drug, you… Read More

Onglyza Linked to Heart Failure

Onglyza Linked to Heart Failure

Did you know that Onglyza may increase your risk of being hospitalized for heart failure? New studies have shown a dangerous link between Onglyza (saxagliptin) and heart problems. Several wrongful death Onglyza lawsuits have already been filed across the country. If you or a loved one have been affected by the drug, you may be… Read More

Woman Says Onglyza Led to Her Mother’s Heart Failure

Woman Says Onglyza Led to Her Mother’s Heart Failure

Onglyza is a Type 2 diabetes drug, classified as a DPP-4 inhibitor. It works by making the pancreas create insulin and preventing the liver from producing extra sugar. Recently, however, the drug has been under scrutiny due to an emerging link between Onglyza and heart failure. This risk of heart failure, along with the potential… Read More

FDA Rejects AstraZeneca’s Onglyza Combo Drug

FDA Rejects AstraZeneca’s Onglyza Combo Drug

AstraZeneca, the manufacturers of Type 2 diabetes drug Onglyza, has had its application for a new combo drug turned down by the U.S. Food and Drug Administration (FDA). The FDA says that the two drugs Forxiga and Onglyza have not been investigated enough to determine the risks involved with the combination of the two. The… Read More

Onglyza Linked to Pancreatic Cancer and Heart Failure

Onglyza Linked to Pancreatic Cancer and Heart Failure

The Type 2 diabetes medication Onglyza may do more harm than good. In fact, recent studies have found that the drug could increase the risk of pancreatic cancer and heart failure. Drug manufacturers have a duty to make sure their products are safe and that the health benefits outweigh the risks. Unfortunately, the makers of… Read More

Filing An Onglyza Lawsuit

Filing An Onglyza Lawsuit

Onglyza is a medication used to help maintain healthy blood sugar levels in patients with Type 2 diabetes. It works by triggering the pancreases’ insulin production. But did you know that the drug may come with risks such as pancreatic cancer, thyroid cancer, and heart failure? That’s why Onglyza lawsuits are currently being investigated across… Read More